TransMedics Group Inc
TMDX
$80.04+2.39%
Delayed · as of Oct 13, 2026, 2:00 PM ET
Mkt cap
$2.53B
EV/Sales
3.39
P/E ratio
N/A
FY2025 Revenue
$605.49M
EPS (TTM)
$3.86
Gross Margin (FY2025)
59.92%
Profit Margin (FY2025)
31.43%
Beta
N/A
Div yield
N/A
Sector
Healthcare
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported TMDX revenue for 2025-12-31 was $605.5M. Net income was $190.3M. Revenue was up 37.1% from 2024-12-31 to 2025-12-31. TMDX currently screens at market cap $2.53B.
Use this TMDX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TMDX income, balance, and cash tables.
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
TransMedics Group Inc (TMDX) is a medical devices company in the Healthcare sector.
Latest cached TransMedics Group Inc (TMDX) revenue for Dec 31, 2025 was $605.5M. Net income was $190.3M. Statements: https://lician.com/financials/tmdx
TransMedics Group Inc (TMDX) market capitalization is $2.53B on the latest cached snapshot.
TransMedics Group Inc (TMDX) cached previous close $78.17; day range $78.17 – $80.04; volume 401,522. Session quote: https://lician.com/quote/tmdx
TransMedics Group Inc (TMDX) latest cached earnings event is "TMDX earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TMDX filing is 8-K · Sep 10, 2026. Filings: https://lician.com/sec/tmdx